Frequently used phrases + helpful hints for Coordinators
If you cannot find the answer to your question, please contact Nina Bracken (ngrude@uic.edu), Gem Roy (groy2@jhu.edu), and the RELIANCE general email for the DCC (jhsph.reliance@jhu.edu).
I. Study introduction
1. How should I use the study overview document?
We have recorded an example of a "Coordinator" and a "Participant" using the Study Overview here: https://youtu.be/P3e7eqom_2s
2. How should I introduce the Participant Portal?
The Participant Portal is a tool developed to provide participants a single place to manage study activities and view study resources.
When should you introduce the portal (in-person or remote): When reviewing the consent in-person or remote
How should you introduce the portal: Emphasize the portal as another option to fit participant’s schedules
Here is a suggested introduction: There is another way to let us know how you are doing. Instead of us calling you, you can log into the RELIANCE participant portal and complete short follow-up surveys there, at a time that is convenient for you. You don’t need to coordinate with the RELIANCE call center because you will log yourself in using your computer or ipad. It’s simple to use and I can walk you through the steps. We will send you reminders about when the surveys should be completed, this way you can participate in the study on your own time, and don’t have to speak to anyone if you don’t want to.
3. How should I address questions about antibiotic resistance and the text on Page 7 of the consent form (Common side effects in people taking Azithromycin or placebo were decreased ability of antibiotics to fight infections)?
In the clinical trials that were done there was no increase in infections due to resistant organisms. If participants should get an infection we would want to treat them with an antibiotic other than AZ. Remind them that AZ reduces respiratory infections.
4. How should I address questions about inability to pay for yet another medication?
Coordinators can inform participants during the consent process that roflumilast costs more than azithromycin but it’s usually covered by insurance if they have any prescription drug coverage. Let the participants know that if either treatment disagrees with them for reasons such as pay, side effects, difficulty getting it, insurance etc., we will continue to take care of them according to best medical practice.